Financial statements Bionanopark
Balance sheet data of BIONANOPARK
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 62 294 160,35 | 74 122 142,49 | 69 763 497,06 |
| A. Fixed assets | 59 358 464,61 | 73 365 128,42 | 55 942 669,31 |
| B. Current assets | 2 935 695,74 | 757 014,07 | 13 820 827,75 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
| Total liabilities | 62 294 160,35 | 74 122 142,49 | 69 763 497,06 |
| A. Equity | 23 871 542,04 | 31 377 414,04 | 25 175 716,83 |
| B. Liabilities and provisions for liabilities | 38 422 618,31 | 42 744 728,45 | 44 587 780,23 |
| I. Long-term liabilities | 0,00 | 4 224 319,41 | 4 832 997,98 |
| II. Short-term liabilities | 3 990 080,92 | 6 091 304,10 | 7 685 601,37 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.